Innovation
Periodic measurement with regular glucose meters is not enough, and that's a fact!
Continuous blood glucose monitoring devices are the most advanced and widely applicable.
Increased Demand
General situation in the world shows annual increase in the number of people who need to monitor their blood glucose levels.
The wide range of CGM applications, both as diagnostic and measurement monitoring, adds to this figure.
Low Competition
The greatest surge in the distribution of CGM devices has occurred in the last five years, so there are quite few manufacturing companies in the world, which offers a wide growth potential for new companies in the market.
Market Outlook
The third quarter of 2021 saw 3 times as many investment deals in the medtech market as compared to 2018, according to the Silicon Valley Bank report.
Venture capital sees growth potential in medical innovation.
CGM devices are already gaining ground among consumers, but are not yet widely available to some categories of people in different countries.
The Product's High Return on Investment
By investing in the project in its early stages you can multiply your capital by up to 1,000 times.
Capitalization of companies already present in the market amounts to billions of dollars.
Our goal is to enter the international market with a product in demand and make it available to a wider range of people in the world, which means a high profit, 50% of which will be assigned to pay dividends to the investors.
